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Type 1 Gaucher disease (GD), a non-neuronopathic lysosomal storage disorder, results from the deficient activity
of acid b-glucosidase (GBA). Type 1 disease is panethnic but is more prevalent in individuals of Ashkenazi Jewish
(AJ) descent. Of the causative GBA mutations, N370S is particularly frequent in the AJ population, ( ),q ∼ .03
whereas the 84GG insertion ( ) occurs exclusively in the Ashkenazim. To investigate the genetic history ofq ∼ .003
these mutations in the AJ population, short tandem repeat (STR) markers were used to map a 9.3-cM region
containing the GBA locus and to genotype 261 AJ N370S chromosomes, 60 European non-Jewish N370S chro-
mosomes, and 62 AJ 84GG chromosomes. A highly conserved haplotype at four markers flanking GBA (PKLR,
D1S1595, D1S2721, and D1S2777) was observed on both the AJ chromosomes and the non-Jewish N370S chro-
mosomes, suggesting the occurrence of a founder common to both populations. Of note, the presence of different
divergent haplotypes suggested the occurrence of de novo, recurrent N370S mutations. In contrast, a different
conserved haplotype at these markers was identified on the 84GG chromosomes, which was unique to the AJ
population. On the basis of the linkage disequilibrium (LD) d values, the non-Jewish European N370S chromosomes
had greater haplotype diversity and less LD at the markers flanking the conserved haplotype than did the AJ N370S
chromosomes. This finding is consistent with the presence of the N370S mutation in the non-Jewish European
population prior to the founding of the AJ population. Coalescence analyses for the N370S and 84GG mutations
estimated similar coalescence times, of 48 and 55.5 generations ago, respectively. The results of these studies are
consistent with a significant bottleneck occurring in the AJ population during the first millennium, when the
population became established in Europe.
Introduction
The unique demographic history of the Ashkenazi Jew-
ish (AJ) population and the occurrence of several lyso-
somal storage disorders at high frequency in this group
have attracted considerable interest and debate concern-
ing the mechanism(s) underlying the prevalence of these
diseases among the Ashkenazim (Chase and McCusick
1972; Myrianthopolous et al. 1972; Goodman 1979;
Zlotogora et al. 1988; Bonne-Tamir and Adam 1992;
Motulsky 1995; Zoosmann-Diskin 1995). The recent
availability of high-density genetic maps has facilitated
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the use of linkage disequilibrium (LD) and coalescence
analyses to provide estimated dates for disease-causing
mutations. Earlier applications of these methods to AJ
genetic diseases demonstrated that 190% of the mutant
alleles causing idiopathic torsion dystonia (ITD) arose
from a single founder mutation (Risch et al. 1995). The
relatively recent coalescence point of the ITD mutation
(∼16 generations, corresponding to ∼400 years), coupled
with its relatively high incidence (∼1/300) in the present-
day AJ, underscored the role that nonuniform popula-
tion expansion has in establishing the current high fre-
quency of the ITD disease allele in the AJ. Similar
analyses have been reported for other mutations in the
AJ population, including the coagulation factor XI type
II lesion (Peretz et al. 1997; Goldstein et al. 1999), the
BRCA1 185delAG deletion (Bar-Sade et al. 1998), and
the APC I1307K mutation (Patael et al. 1999). Prelim-
inary studies have suggested that the AJ acid b-glucos-
idase (GBA) mutation, N370S, the most frequent cause
of Gaucher disease (GD [MIM 230800]) in this popu-
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lation, shares a common origin with the allele present
in the non-Jewish European population, but these stud-
ies have not provided a dating estimate for this mutation
(Diaz et al. 1998).
In this study, linkage and haplotype analyses were
used to investigate the origins of the most prevalent
GBA mutations in the AJ population: N370S ( )q ∼ .03
and 84GG ( ) (Eng et al. 1997). For these stud-q ∼ .003
ies, a linkage map of 10 short tandem repeats (STRs)
flanking the GBA gene was constructed and then were
used to genotype AJ and non-Jewish N370S and AJ
84GG chromosomes. Haplotype and LD analyses in-
dicated that the N370S mutation existed in the general
European population prior to the founding, circa the
1st millennium, of the AJ population in Europe. Similar
analyses revealed that GD 84GG chromosomes had a
unique, conserved haplotype, indicating the occurrence
of an ancestral AJ founder. Coalescence analyses sug-
gested that the N370S and 84GG mutations coalesced
in the AJ population 48 and 55.5 generations ago
(∼1,200–1,400 years before present [YBP]), around the
time that the AJ population became established in
Europe.
Subjects, Material, and Methods
Subjects and Sample Collection
Blood was obtained, with informed consent, from pa-
tients with GD type 1 and from relevant family members
with GBA mutations N370S and 84GG who were en-
rolled in the study; these individuals included N370S
homozygotes, N370S heterozygotes, and N370S/84GG
compound heterozygotes. By means of the Puregene
DNA isolation kit (Gentra), genomic DNA was isolated
from peripheral leukocytes. Phasing of the STR markers
on mutation-bearing chromosomes was initially per-
formed with a subset of 25 AJ and 29 non-Jewish Eu-
ropean N370S chromosomes and 4 AJ 84GG chromo-
somes, from families in which parents and/or siblings
were also available. In addition, 60 AJ and 7 Portuguese
homozygotes were studied to determine the allele fre-
quencies of the STRs. To obtain allele-frequency data
on the 84GG chromosomes, 32 N370S/84GG com-
pound heterozygotes were analyzed. To assess other eth-
nic groups for the presence of the common N370S foun-
der haplotype, 18 N370S chromosomes from patients
of various ethnic origins were haplotyped, including pa-
tients with type 1 GD who were of British ( ), Greekn = 8
( ), Macedonian ( ), Sephardic Jewish ( ),n = 4 n = 2 n = 2
Algerian ( ), and West Indian ( ) ancestry.n = 1 n = 1
On the basis of preliminary findings, a second set of
AJ subjects, including 58 N370S homozygotes and 36
N370S/84GG compound heterozygotes, were genotyped
for coalescence analyses. Analysis of the first set of sub-
jects revealed that the most informative markers for LD
analysis of N370S chromosomes were D1S2624 and
D1S1600; therefore, only these markers were typed for
the additional N370S homozygotes. Similarly, initial
results indicated that markers D1S305 and D1S2715
were most informative for 84GG chromosomes, so only
these markers were typed for 84GG/N370S compound
heterozygotes.
Linkage Mapping
Searching the public databases of the Whitehead In-
stitute for Biomedical Research/MIT Center for Genome
Research and The Cooperative Human Linkage Center
identified maximally informative polymorphic STR
markers mapping to 1q21; these included D1S305,
D1S1595, D1S1600, D1S1653, D1S2128, D1S2624,
D1S2715, D1S2721, D1S2777, and the trinucleotide-
repeat marker PKLR. For linkage analysis, genotype
data for these markers were obtained from 61 of the
CEPH reference families, representing 1,036 meioses.
STRs were PCR-amplified under standard conditions
(Hudson et al. 1995)—except for markers D1S1595 and
D1S1600, which required annealing temperatures of
617C and 507C, respectively. The map order and distance
between the markers were determined by use of the
MultiMap software package (Matise et al. 1994).
Analysis
To estimate allele frequencies on population-specific
control chromosomes, as required for LD analysis, 83
AJ chromosomes (39 from family members of patients
with GD plus 44 from unrelated AJ families), 63 French
chromosomes (15 from unaffected family members plus
48 from French CEPH families) and 61 Portuguese chro-
mosomes (25 from unaffected family members plus 36
from random unrelated individuals) were surveyed.
Allele frequencies were determined by direct allele
counting.
Estimates of marker-allele frequencies for N370S
chromosomes from French and Portuguese subjects also
could be obtained directly by allele counting, and var-
iances of these frequencies were obtained with the for-
mula where p is the observed frequency andp(1 2 p)/N,
N is the number of alleles. The situation was more com-
plicated for the AJ population, because of the inclusion
of the N370S/84GG compound heterozygotes. In this
case, the EM algorithm was used to obtain maximum-
likelihood estimates (MLEs) of the allele frequencies
(Ceppellini et al. 1995; also see the Appendix). Signifi-
cance of LD was then assessed by comparison of allele
frequencies of mutation-bearing chromosomes versus
those of control chromosomes. Specifically, let pI and jp
be the allele frequency and its standard error for allele
i on mutation-bearing chromosomes, and let ri and jr be
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the corresponding frequency and standard error for con-
trol chromosomes. Then, statistical significance can be
derived by the statistic . Because2 2ÎZ = (p 2 r)/ j 1 ji i p r
multiple alleles were tested at a locus, a statistical cor-
relation for multiple tests was employed. A Bonferroni
correction was applied by multiplication of the obtained
significance level, P, for a one-sided test (since each allele
was tested for evidence of increased frequency on mu-
tation chromosomes) by the number of alleles tested.
Every allele with a frequency 15% on the mutation chro-
mosomes was tested, and, therefore, nominal P values
were multiplied by the number of such alleles, to obtain
a final P value. This correction may be conservative,
especially for loci with a large number of alleles. In these
cases, we also considered the anticonservative correc-
tion, , where n is the number of alleles tested,n1 2 (1 2 P)
to determine a range for the actual P values
The degree of LD at loci flanking the conserved core
markers was assessed by calculation of the parameter d
(Bengtsson and Thomson 1981; Risch et al. 1995).
Chromosomes bearing the conserved haplotype (defined
as markers varying, from the consensus sequence, at no
more than one position) were identified in each popu-
lation, and associated allele frequencies were calculated
for the flanking markers as described above. The d value
was obtained by use of the formula ,d = (p 2 r)/(1 2 r)
where p is the frequency of the associated allele on mu-
tation-bearing chromosomes and r is the frequency of
the same allele on control chromosomes. A confidence
interval for d was calculated under an assumption of
independence for the sampled chromosomes. Since d =
is a function of the ratio of two in-1 2 (1 2 p)/(1 2 r)
dependent random variables, the variance of d can be
approximated by
21 jp2 2 2( ) ( )Var d = j j 1 1 2 p 1 .( )r p4 2( ) ( )1 2 r 1 2 r
An approximate confidence interval of d can then be
obtained as , where .2d 1 1.96j j = Var(d)d d
To estimate the coalescence time for the founder mu-
tations, or the number of generations to the most recent
common ancestor (MRCA), the formula used was
lnd
G = , (1)
ln(1 2 v)
where v is the recombination fraction with regard to the
marker analyzed (Risch et al. 1995). For calculation of
G, the GBA locus was assumed to colocalize with
D1S2777, since the degree of LD observed on N370S
and 84GG chromosomes was generally highest at this
marker. A minimum confidence interval for G was cal-
culated by use of the formula given above, with the
minimum confidence interval for d.
It is difficult to calculate a confidence interval for the
estimate of G, because, under the assumption of LD, the
mutation-bearing chromosomes are not independent
(Risch et al. 1995; Rannala and Slatkin 1998). The de-
gree of nonindependence—and, hence, the confidence
interval—is strongly influenced by assumptions regard-
ing the demographic history of the population. Rapid
expansion after initial introduction of the mutation leads
to greater statistical independence and smaller confi-
dence intervals, whereas constant population size leads
to less statistical independence and broader confidence
intervals (Rannala and Slatkin 1998; Goldstein et al.
1999). Here we provide a minimum confidence interval
for G, using the calculated 95% confidence interval for
d and equation (1). We note that this interval is appro-
priate only for a rapidly expanding mutation (which is
not unlikely for the mutations under consideration here)
and that the true confidence interval may be substantially
larger. A more refined estimate of G, by examination of
multiple markers simultaneously, might be possible in
theory; however, in this case, because most of the chro-
mosomes are unphased, it is not clear that such would
be easily implemented or of great benefit.
Results
Genotyping Reveals a Founder N370S Haplotype
To facilitate haplotype and LD analyses of the GD
N370S and 84GG mutations, a genetic map of poly-
morphic STR markers flanking the GBA gene was con-
structed (fig. 1). The genetic map spanned 9.3 cM and
contained 10 STRs, several of which were at no meas-
urable recombination distance from each other. The
GBA gene was positioned relative to the mapped STRs,
on the basis of available physical-mapping and sequence
data for the GBA region and for the relevant STRs. The
5′ end of GBA is 71 kb upstream of the 5′ end of the
liver-specific pyruvate kinase gene (Demina et al. 1998).
An intragenic trinucleotide repeat in intron 11 of this
gene, PKLR (Lenzner et al. 1994), colocalized with
markers D1S1595 and D1S2721 on the genetic linkage
map. Physical-mapping data placed GBA on YACs con-
taining marker D1S2777. Thus, the GBA locus lies very
close to the four central markers PKLR, D1S1595,
D1S2721, and D1S2777.
For the N370S mutation, 54 homoallelic or hetero-
allelic AJ individuals in 19 families were genotyped
for the 10 mapped STRs. Haplotype analysis of these
families with GD revealed a highly conserved 6-5-4-6
haplotype for the markers PKLR-D1S1595-D1S2721-
D1S2777, respectively (table 1). Additional genotyping
of 61 AJ patients who were homoallelic for the N370S
mutation demonstrated conservation of the ancestral
haplotype at three or all four of these core STRs, in 133
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Figure 1 Linkage map of the GBA region. The order of 10 poly-
morphic STRs flanking the GBA gene on 1q21 was determined by
linkage mapping using families from the CEPH panel. Markers are
arrayed from centromere (top) to telomere (bottom), with the obtained
recombination distances shown. The position of the GBA gene as de-
rived from physical mapping, sequence, and LD data is indicated.
Table 1
Allele-Frequency Estimates for N370S, 84GG, and CEPH Control
Chromosomes, for the Central Four Markers
MARKER
AND
ALLELEa
FREQUENCY OF CHROMOSOMES
Controls
CEPH)
N370S 84GG
Ashkenazim French Portuguese Ashkenazim
N = 400 N = 117 N = 17 N = 23 N = 37
PKLR:
1 .165 .000 .000 .043 .865
2 .092 .009 .000 .000 .135
3 .362 .009 .118 .000 .000
4 .215 .026 .059 .000 .000
5 .080 .026 .059 .000 .026
6 .078 .932 .706 .783 .015
7 .008 .000 .059 .174 .000
N = 388 N = 142 N = 26 N = 39
D1S1595:
2 .131 .007 .000 .000 .000
3 .062 .000 .000 .077 .000
4 .000 .000 .000 .077 .000
5 .330 .958 .824 .731 .078
7 .294 .028 .118 .115 .948
8 .103 .007 .059 .000 .000
N = 374 N = 137 N = 16 N = 26 N = 38
D1S2721:
1 .024 .007 .000 .000 .000
2 .064 .007 .000 .077 .000
3 .219 .029 .038 .077 .000
4 .235 .905 .563 .577 .000
5 .045 .007 .063 .038 1.000
6 .094 .015 .063 .038 .000
7 .035 .007 .000 .000 .000
8 .275 .022 .313 .192 .000
N = 420 N = 147 N = 17 N = 27 N = 39
D1S2777:
2 .000 .000 .000 .000 .000
3 .021 .000 .000 .000 .000
4 .093 .007 .059 .148 .000
5 .198 .014 .059 .111 1.000
6 .543 .973 .882 .741 .000
7 .064 .007 .000 .000 .000
a For clarity of presentation, uncommon alleles that are not present
in disease chromosomes have been omitted.
(95%) of the total 140 informative AJ N370S alleles,
with only seven chromosomes varying at two or more
STRs (table 2). Of note, the conserved haplotype was
uncommon, found in only 3 (3.6%) of 83 of the control
AJ chromosomes (data not shown). These could also be
N370S carriers, since the population frequency of the
mutation is ∼6% (Eng et al. 1997).
Genotyping of non-Jewish European patients with GD
type 1 who were homoallelic or heteroallelic for the
N370S mutation revealed the same founder haplotype
in the majority of individuals (table 1). This group in-
cluded 13 Portuguese and 12 French families with GD,
from which 14 Portuguese and 15 French N370S hap-
lotypes were phased. An additional 14 Portuguese and
2 French chromosomes from patients homoallelic for
N370S also were genotyped. The ancestral 6-5-4-6 hap-
lotype was not detected in 44 French control haplotypes
(29 derived from French families in the CEPH Genotype
Database and 15 derived from unaffected French indi-
viduals in this study) or in 25 Portuguese control hap-
lotypes, thereby confirming its rarity in these popula-
tions. Thus, a majority of the N370S alleles in AJ and
non-Jewish European populations shared the common
6-5-4-6 haplotype.
Among the French and the Portuguese N370S chro-
mosomes, the degree of allelic diversity at the conserved
core markers was strikingly greater than that in the AJ
chromosomes. Approximately 18% (3 of 17) and 33%
(10 of 27) of French and Portuguese N370S chromo-
somes, respectively, varied from the ancestral 6-5-4-6
haplotype at two or more markers, as compared with
5% of the AJ N370S chromosomes (table 2). Indeed,
the frequency of the associated founder allele for each
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Table 2
Conservation of N370S Chromosomes from Various
Origins
POPULATION
NO. OF N370S
CHROMOSOMES
% OF N370S
CHROMOSOMES
CONSERVEDTotal Ancestrala
Ashkenazi 140 133 95
Portuguese 28 18 64
French 17 14 82
Other 18 15 83
a At least three of the four core haplotype markers
are conserved.
of the four loci was significantly lower ( ) in bothP ! .05
the French and the Portuguese N370S chromosomes
than in the AJ N370S chromosomes (table 1). This ob-
servation could be explained either by greater decay of
the conserved haplotype in the non-Jewish populations
or by recurrent N370S mutations in different haplo-
types. The former possibility would imply that the
N370S founder mutation had existed for a longer time
in the non-Jewish populations than in the Ashkenazim
and suggests the direction of gene flow for this particular
allele.
Genotyping also was performed on GD N370S chro-
mosomes of British ( ), Greek ( ), Macedoniann = 8 n = 4
( ), Sephardic Jewish ( ), Algerian ( ), andn = 2 n = 2 n = 1
West Indian ( ) ancestry. Haplotypes were inferredn = 1
for 14 of these 18 chromosomes. The remaining four
chromosomes were from two patients—one Greek and
one Macedonian—who were homoallelic for N370S.
The Greek patient’s genotype was divergent at PKLR,
for both alleles (i.e., 3/5) and at D1S1595 for one allele
(i.e., 5/2); thus, one chromosome had the ancestral hap-
lotype at three of the four conserved markers whereas
the other had only two of the conserved alleles. The
Macedonian patient was heterozygous at all of the mark-
ers, consistent with one completely conserved and one
completely divergent chromosome. Of these 18 N370S
chromosomes from diverse ethnic/demographic groups,
15 (83%) had the ancestral 6-5-4-6 haplotype, a fre-
quency comparable to the 82% of ancestral chromo-
somes among the French N370S alleles (table 2).
LD at Markers Flanking the Conserved N370S
Haplotype
Table 3 shows the allele frequencies for the STRs
flanking the conserved 6-5-4-6 markers for the AJ
N370S chromosomes bearing the conserved 6-5-4-6
haplotype, for all the 84GG chromosomes, and for the
control AJ chromosomes. The allele frequencies for
mutation-bearing chromosomes were compared with
those for control chromosomes, to assess LD. For
N370S, four markers showed significant LD. For three
of the markers, a single allele was at significantly in-
creased frequency (D1S2715, allele 9, , cor-Z = 4.11
rected ; D1S2624, allele 5, , correctedP ! .001 Z = 8
; and D1S1600, allele 2, , correctedP ! .001 Z = 7.11
). For D1S305, the situation was more compli-P ! .001
cated; three alleles (alleles 4, 5, and 6) were at increased
frequency, although only the increase in frequency of
alleles 5 and 6 was statistically significant (allele 5,
, corrected ; and allele 6, , cor-Z = 2.94 P ! .01 Z = 3.16
rected ); however, it is likely that either the 4 alleleP ! .01
or 5 allele is the ancestral allele, as detailed below.
Coalescence Estimates for AJ N370S Chromosomes
The presence of detectable LD at markers a defined
map distance from the GBA locus permitted the esti-
mation of the coalescence times for the founder N370S
and 84GG mutations in the AJ population. The d values
given in table 3 (for all markers except D1S305 for
N370S) and the recombination fractions from table 4
were used to calculate the values of G, the number of
generations to the MRCA, for each mutation. As noted
above, several alleles at marker D1S305 appeared to be
associated with the N370S mutation. Therefore, all
N370S chromosomes with the disease-associated allele
9 at D1S2715 (by phasing or homozygosity) were iden-
tified, and the frequencies of the various D1S305 alleles
were calculated for this subset of 69 chromosomes. The
D1S305 allele frequencies were as follows: allele 4,
63.8% ( ); allele 5, 23.2% ( ); allele 6, 3.0%n = 44 n = 16
( ); and allele 8, 10.1% ( ). Two alleles hadn = 2 n = 7
significantly increased frequencies: allele 4 ( ,Z = 2.05
) and allele 5 ( , ). In this subset,P ! .05 Z = 2.59 P ! .01
allele 6 did not have increased frequency. These results
suggested either that allele 4 or allele 5 was the progen-
itor or that an early recombination or mutation event
had led to an increased frequency of both of these alleles
on N370S chromosomes. Therefore, a d value was cal-
culated, by combining of both of these alleles, leading
to a d estimate of [.516 1 .195 2 (.459 1 .071)]/[1 2
(table 4). As noted in table 3, allele(.459 1 .071)] = .385
4 at D1S305 and allele 9 at D1S2715 were very common
in the AJ control chromosomes. Thus, only markers
D1S2624 and D1S1600 were typed in the follow-up set
of N370S chromosomes.
To account for the uncertainty inherent in the map-
ping of tightly linked loci, the v values from the present
study were compared with those from the genetic and
integrated maps publicly available from the Center for
Medical Genetics, Marshfield Medical Research Foun-
dation and The Genetic Location Database of the Uni-
versity of Southampton (table 4). The fact that the me-
dian v values at three of the four markers used for
coalescence analysis were identical to the v values ob-
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Table 3
Allele-Frequency Estimates for N370S, 84GG, and Normal Control Chromosomes, with Associated d Values
LOCUS
AND ALLELE
FREQUENCY (d) IN
AJ Population French Population Portuguese Population
Control N370S 84GG Controls N370S Controls N370S
N = 85 N = 193 N = 58 N = 66 N = 16 N = 24 N = 27
D1S305:
3 .094 .017 .100 .015 .000 .083 .000
4 .459 .516 (.105) .154 .439 .438 (0) .375 .185 (!0)
5 .071 .195* (.133) .059 .015 .125 (.112) .042 .000 (!0)
6 .024 .121* (.099) .027 .152 .313 (.190) .125 .259 (.153)
8 .235 .106 .588 (.461) .227 .125 .167 .056
9 .094 .031 .052 .121 .000 .167 .333
10 .012 .010 .020 .015 .000 .041 .000
N = 83 N = 182 N = 53 N = 58 N = 16 N = 51 N = 26
D1S2715:
2 .000 .006 .452** (.452) .103 .063 .118 .077
3 .108 .015 .165 .052 .063 .059 .038
4 .301 .133 .130 .293 .313 .353 .308
5 .012 .017 .000 .034 .000 .039 .000
6 .060 .060 .000 .000 .063 .000 .000
8 .024 .006 .019 .069 .063 .078 .000
9 .422 .688** (.460) .099 .293 .375 (.120) .333 .500 (.250)
10 .024 .076 .098 .317 .125 .020 .000
N = 83 N = 268 N = 32 N = 60 N = 16 N = 50 N = 24
D1S2624:
1 .024 .000 .000 .050 .125 .000 .000
2 .313 .134 .088 .250 .438 .300 .208
3 .036 .008 .000 .067 .000 .100 .042
4 .373 .198 .912** (.860) .267 .313 .260 .458
5 .205 .631** (.536) .000 .317 .125 (!0) .320 .291 (!0)
6 .048 .030 .000 .000 .000 .000 .000
N = 75 N = 258 N = 32 N = 61 N = 17 N = 24 N = 24
D1S1600:
2 .067 .326** (.316) .000 .033 .000 (!0) .208 .042 (!0)
3 .427 .207 .394 .344 .294 .333 .458
4 .333 .346 .368 .410 .412 .167 .333
5 .173 .075 .238 (.079) .180 .294 .125 .167
* .P ! .01
** .P ! .001
tained in the present study supports the overall accuracy
of the current linkage map. The age estimates for N370S,
for D1S305, D1S2715, D1S2624, and D1S1600, varied
with the genetic map used but ranged from a minimum
of 17 generations (marker D1S2624) to a maximum of
136 generations (marker D1S305), both estimates being
based on the Southampton map. When the medians of
the v values from the three maps were used, the range
was 32–68 generations. The minimum confidence inter-
vals when median v values were used were 37–123 gen-
erations for D1S305, 34–84 generations for D1S2715,
31–53 generations for D1S2624, and 26–40 generations
for D1S1600. The latter two were based on substantially
larger sample sizes. The median value for G was 48
generations. If it is assumed that a generation comprises
25 years, the coalescence time for this mutation was
1,200 YBP, or approximately year 800 of the common
era (C.E.). It is noteworthy that the founding of the AJ
population at ∼900 C.E., when several thousand Jews
migrated into the Rhineland and subsequently expanded
into a much larger population (Weinryb 1972), falls
within the confidence intervals for these estimates of the
coalescence. We note that our analysis did not include
mutation at the markers (e.g., see Goldstein et al. 1999).
Presumably, the marker mutation rate is substantially
less than the recombination rate considered here (i.e.,
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Table 4
Estimates of Coalescence Generations for N370S and 84GG Chromosomes in the AJ Population.
MARKER
N370S 84GG
d
G (v)a
d
Ga
Marshfield Southampton
Present
Study Median Marshfield Southampton
Present
Study Median
D1S305 .385 56 (.017) 136 (.007) 68 (.007) 68 (.014) .461 45 110 55 55
D1S2715 .460 45 (.017) 111 (.007) 55 (.007) 55 (.014) .452 46 113 56 56
D1S2624 .536 41 (.015) 17 (.036) 69 (.009) 41 (.015) .860 10 4 17 10
D1S1600 .316 38 (.030) 29 (.039) 32 (.035) 32 (.035) .079 83 64 71 71
a Recombination distances Marshfield = Center for Medical Genetics, Marshfield Medical Research Foundation; Southampton = The
Genetic Location Database of the University of Southampton. v Values are from the various maps, under the assumption that GBA
colocalizes with D1S2777.
1.5%–3.5%). Inclusion of mutation within the coales-
cence analysis would lead to coalescence times slightly
more recent than those given in table 4.
LD Analysis of the Non-Jewish N370S Chromosomes
The degree of LD with associated alleles on N370S
founder chromosomes in the AJ population can be con-
trasted with that in the French and Portuguese popu-
lations (table 3). At D1S2715, the associated allele 9,
which has a d value of .46 in the AJ population, was
also associated in the French and Portuguese popula-
tions, but to a lesser extent ( for the Portuguesed = .25
population, and for the French population), andd = .12
the difference was statistically significant for each (P !
). At D1S2624, the associated allele 5 allele was not.05
increased in the Portuguese or the French samples (d !
, ). Finally, at D1S1600, the associated allele 20 P ! .05
allele was not increased in either the Portuguese or the
French populations (again, ). Indeed, no otherP ! .05
consistent allelic associations at any of these markers
were present in the Portuguese and the French popula-
tions. This could not be due to the smaller sample size
of the French and the Portuguese populations, since a
comparable level of LD (i.e., or .536) would haved = .46
also been statistically significant in those populations.
Thus, there was minimal LD on N370S progenitor chro-
mosomes at 0.9%–1.5% recombination distance in
the non-Jewish European populations. These results
strongly suggest that the origin of the founder N370S
mutation was more widespread and more ancient than
it would be if it had occurred with the founding of the
AJ population.
Although the absence of significant LD in the non-
Jewish European population precluded direct coales-
cence analysis, it was possible to estimate the relative
age of the N370S mutation in this population. The age
of a mutation in a population is proportional to logd,
so that, even in the absence of known v values, the ratio
of ages can be computed by the ratio of the logd values.
Table 5 show, for the four conserved markers, the d
values and the ratios of logd values in the AJ population
versus those in the French or the Portuguese populations.
For the French population, the median R value is 5.0;
for the Portuguese population, the median R value is
7.0; and the median R value for both populations is 5.6.
Assuming an age of 1,200 years for the AJ population
gives an estimate age of ∼6,700 years for the non-Jewish
European N370S mutation. This value may be a slight
overestimation, because of the inclusion of de novo mu-
tations, as discussed below. Nonetheless, it suggests that
little LD existed at the flanking loci in the extant pop-
ulation at the time of the founding of the Ashkenazim
and that survival of a single AJ N370S chromosome
from the founding has led to LD at the adjacent markers.
Evidence of De Novo N370S Mutations
The allelic diversity at the conserved N370S 6-5-4-6
haplotype, especially in the non-Jewish populations,
raised the possibility of distinct, recurrent mutations.
Thus, N370S chromosomes carrying atypical haplotypes
were screened for the Pv1.1 intragenic polymorphism
(Horowitz et al. 1989). This marker is one of 12 intra-
genic polymorphisms in the GBA gene that form two
haplotypes (i.e., 1 and 2) that are in complete LD with
each other. The (2) haplotype occurs at a frequency of
∼.7 in the general population and has been invariably
associated with the N370S mutation, a finding that is
suggestive of a common founder mutation for the N370S
allele (Zimran et al. 1990; Beutler et al. 1992). Of the
23 atypical chromosomes, defined as having two or more
variant alleles at the conserved 6-5-4-6 haplotype, 3 had
a Pv1.1(1) allele (table 6), which was confirmed by di-
rect sequencing (not shown), providing evidence of re-
current N370S mutations. If a proportion, q, of these
23 atypical chromosomes were nonancestral, then .3q
would be the frequency of the Pv1.1(1) alleles among
these chromosomes. Thus, , so that we.3q = 3/23 = .13
can estimate q as .43; that is, 43% of the atypical hap-
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Table 5
d Values and Ratio, R, of logd, for French and
Portuguese N370S Chromosomes, Compared with
Those of AJ Chromosomes
MARKER
d (R) FOR
AJ
Population
French
Population
Portuguese
Population
PKLR .926 .681 (5.0) .765 (3.5)
D1S1595 .937 .737 (4.7) .598 (7.9)
D1S2721 .876 .429 (6.4) .447 (6.1)
D1S2777 .941 .742 (4.9) .433 (13.8)
Table 6
Atypical N370S Chromosomes
POPULATION
ALLELE(S) FOR MARKER
Pv1.1
ALLELE(S)PKLR D1S1595 D1S2721 D1S2777
Ashkenazim 6 7 7/4 4 2
4 8 8/3 6 2
5 5 3 6 2
3/4a 5/7 5/8 6/6 2/2
4/2a 7/5 8/1 6/6 1/1
Portuguese 6 5 8 4 2
7 4 4 6 2
7 5 8, 5 4 2
No data 5/5 8/8 5/5 2/2
6/6a 7/7 2/2 4/6 2/2
6/1a 3/5 8/3 5/4 2/2
French 5 5 8 6 2
6 7 8 6 2
7 5 8/5 4 2
Macedonian 5/6a 8/5 3/4 5/6 1/2
Greek 3/5a 2/5 4/4 6/6 2/2
English 6 7 8 7 22
a Unphased genotype data from N370S homozygotes.
lotypes carry de novo mutations, while the remainder
represent recombination or marker mutation events.
Haplotype and LD Analyses for the 84GG Mutation
The presence of a conserved haplotype at the markers
PKLR-D1S1595-D1S2721-D1S2777 was apparent from
examination of the N370S/84GG genotype data. At each
marker, two alleles were much more frequent than they
were in control chromosomes, with the first allele cor-
responding to the conserved N370S allele and with the
second allele defining the conserved 84GG allele. The
allele frequencies given in table 1 were calculated by
direct counting of the non-N370S allele at each marker,
except in two individuals, one of whom was heterozy-
gous for a nonconserved N370S allele and the other of
whom was heterozygous for a conserved 84GG allele at
single markers. These alleles defined a 1-7-5-5 haplotype
at the markers PKLR-D1S1595-D1S2721-D1S2777 for
the 84GG chromosomes. Phasing of four 84GG chro-
mosomes demonstrated that three of these chromosomes
had the completely conserved haplotype and that the
fourth had a single variation (i.e., allele 2 at PKLR).
Thus, the haplotypes from the phased chromosomes
concurred with the haplotype predicted by the allele-
frequency estimates.
The allele frequencies at nonconserved markers in the
84GG chromosomes were estimated by maximum like-
lihood (see Subjects, Material, and Methods). As seen
in table 3, three markers flanking the conserved hap-
lotype showed significant LD, which, in each case, was
attributable to a single allele (D1S305, allele 8, Z =
, corrected ; D1S2715, allele 2, ,4.16 P ! .001 Z = 6.52
corrected ; and D1S2624, allele 4, ,P ! .001 Z = 7.17
corrected ). At D1S1600, one allele (allele 5)P ! .001
was modestly increased but did not reach statistical
significance.
Coalescence Analysis of the 84GG Mutation
Coalescence analysis of the 84GG mutation gave sim-
ilar age estimates for the two proximal markers, D1S305
and D1S2715 (table 4), but gave somewhat disparate
results for the distal markers, D1S2624 and D1S1600.
When median v values were used, the minimum confi-
dence intervals for D1S305, D1S2715, and D1S1600
were overlapping (30–93, 38–81, and 33–` generations,
respectively). The interval for D1S2624 (0–25 genera-
tions) did not overlap the minimum intervals for the
other three markers, perhaps reflecting the fact that these
are minimal intervals and do not account for potential
errors in v. A median value of G for the 84GG chro-
mosomes was ∼55.5 generations (or ∼1,400 YBP), sim-
ilar to that observed for N370S. This is probably a rea-
sonable estimate, because marker D1S2715 ( )G = 56
provided the greatest accuracy, since allele 2 on 84GG
chromosomes was absent on control chromosomes and
was nearly absent on N370S chromosomes. In contrast,
the associated D1S2624 allele 4 ( ) was very com-G = 10
mon (frequency .373) on control chromosomes.
Discussion
In the present article, we have reported detailed hap-
lotype and LD analyses that build on our earlier work
(Diaz et al. 1998), in an attempt to determine the genetic
history of the GBA N370S and 84GG mutations causing
GD. Previous studies of the intragenic GBA polymor-
phism, Pv1.1 in intron 6, found that all N370S chro-
mosomes examined occurred on the Pv1.1(2) haplotype
(Zimran et al. 1990; Beutler et al. 1992; Lacerda et al.
1994a). The results of those studies were suggestive of
a common founder but were not conclusive, since the
(2) haplotype was found to have a population frequency
of ∼.7 (Beutler et al. 1992; Lacerda et al. 1994a). In
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contrast, the results described here clearly demonstrate
that most N370S chromosomes derive from an ancestral
founder. In addition, our study has documented the ex-
istence of de novo N370S mutations occurring on a
Pv1.1(1) haplotype. Such alleles are uncommon, since
only three Pv1.1(1) alleles were identified in the 303
N370S chromosomes haplotyped. The mechanism of re-
currence is unclear, since the mutation does not occur
at a CpG dinucleotide; nor are degenerate repeat motifs
present that could contribute to replication errors.
Because of its high prevalence in the AJ population,
N370S has been considered to be a Jewish mutation. It
was speculated that its presence in non-Jewish European
populations might have resulted from AJ admixture
(Lacerda et al. 1994b). However, the results of LD anal-
yses reported here, of N370S chromosomes with the
ancestral haplotype from AJ and from non-Jewish
French, Portuguese, and other ethnic groups, are not
consistent with gene flow from the AJ into the non-AJ
population. Despite the fact that the conserved four
haplotype markers tightly linked to the GBA locus show
very strong disequilibrium for the N370S chromosomes,
only the AJ chromosomes show detectable LD at the
more distant markers on the 9.3-cM map. The increased
allelic diversity in non-Jewish N370S chromosomes
compared with that in the AJ N370S chromosomes is
consistent with a more ancient coalescence point of
N370S in the non-Jewish European populations. The
age estimate (∼6,700 YBP) of the non-Jewish European
N370S mutation, calculated by means of the ratio of
the logd values, suggests that little LD existed at the
flanking markers in the extant population at the time
of the Ashkenazi founding and that survival of a single
AJ N370S chromosome from the founding has led to
LD at these adjacent markers.
Although confidence intervals are given for the esti-
mates of the mutation coalescence in this study, there
are several additional sources of uncertainty that are
worth noting. First, map distances and even some
marker orders varied among the available genetic maps.
This is not surprising, since the short distances (and
correspondingly small number of observed recombinant
events between markers) can be readily altered by small-
sample bias or by single genotyping errors. Second, the
position of the GBA gene relative to the four conserved
markers is not precisely known. The G- estimate cal-
culations reported here assume that GBA colocalizes
with D1S2777, for two reasons: (1) the d values for the
AJ and the French N370S chromosomes and for the AJ
84GG chromosomes were maximal at this marker, and
(2) instances of alternative alleles for D1S2777 on
N370S chromosomes were generally consistent with
mutation at the marker (i.e., the flanking markers were
conserved), whereas this was less true for the other three
central markers. Third, coalescence analysis does not
distinguish recombination between markers from mu-
tations of a marker. High mutation frequencies, which
lead to the allelic variability that make these markers
polymorphic, tend to reduce d values and to result in a
more ancient estimate for the coalescence time. Even if
we account for these sources of uncertainty, it is striking
that the confidence intervals for the coalescence times
of the N370S and 84GG mutations include the ap-
proximate time of the Ashkenazi founding, supporting
a founder effect to explain the prevalence of these mu-
tations in the population.
Our mutation-dating results are widely discrepant
with those in a recent letter comparing haplotypes ob-
served in AJ and Spanish patients with GD and dating
the N370S mutation in the Jewish population to an
interval ∼4,200–9,500 YBP (Diaz et al. 1999). Although
some variation can be attributed to the use of different
map distances, this large discrepancy suggests the ex-
istence of a calculation error. When the data presented
in that report and the median recombination distance
described above were used to estimate G, a value of
generations was obtained, in close agreementG = 50
with the results of the present study.
Several disease mutations present in the AJ can be
traced back to Middle Eastern progenitor Jewish pop-
ulations. These include the factor XI type II mutation
(Peretz et al. 1997; Goldstein et al. 1999), the BRCA1
185delAG mutation (Bar-Sade et al. 1998), and the APC
I1307K mutation (Patael et al. 1999). These examples
appear to be ancient mutations that are unique to the
Jewish people. In contrast, the results reported here in-
dicate that the N370S founder haplotype exists widely
in non-Jewish European chromosomes. The distribution
of the N370S mutation is more like that of the factor
II polymorphism, G20210A, which is associated with
an increased risk of thromboembolism. The G20210A
allele is found at high prevalence among the AJ but is
also found at lower levels in various non-Jewish pop-
ulations (Zivelin et al. 1998). The presence of this factor
II mutation in multiple European populations, in con-
junction with its absence in non-European populations,
suggests that it originated in an ancient progenitor pop-
ulation postdating the divergence of European and
Asian populations. The same inference can be made for
the N370S mutation, which has not been found in any
Asian populations studied to date (Kim et al. 1996;
Choy et al. 1997; Eto and Ida 1999).
The underlying genetic mechanism(s) accounting for
the high prevalence of the N370S and 84GG mutations
in the AJ population, as well as for other common AJ
mutations, has been the subject of considerable debate.
The relatively high prevalence of several lysosomal dis-
orders in the AJ population, each resulting from several
independent mutations, suggests the hypothesis that
heterozygote advantage was the operative genetic mech-
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anism. Although this suggestion is intuitively appealing,
a clear biological benefit of heterozygosity for these
lysosomal mutations has never been documented. The
finding that a common N370S allele is concurrently
present in the AJ population and in the neighboring
non-Jewish European populations allows some infer-
ences to be drawn. To explain the current N370S allele
prevalence among the AJ by heterozygote advantage
would require that selection operate only in this pop-
ulation and not on proximate non-AJ populations. In
instances in which heterozygosity has conferred de-
monstrable selective advantage to human populations,
by affecting susceptibility to common infectious dis-
eases, such uneven selection has not been observed. Se-
lection for b-globin mutations, which offer protection
against malarial infection (Williams et al. 1996), has
been observed in multiple populations inhabiting ma-
laria-endemic regions. Similarly, the prevalence of the
HIV-coreceptor mutation, CCR5D32, is approximately
the same in the AJ population as in other, northern-
European populations. This mutation, which has no
disease phenotype, is proposed to have recently risen to
its current frequency of .10–.13 in northern-European
populations by conferring immunity to bacterial path-
ogens that enter cells by means of the CCR5 receptor
(Libert et al. 1998; Stephens et al. 1998). If heterozy-
gosity for N370S confers resistance to a common path-
ogen, it is unlikely that increased allele prevalence
would be limited to the AJ population.
In contrast to N370S, the 84GG mutation is unique
to the AJ population and appears to coalesce at ap-
proximately the same historical period as does the
N370S lesion. If the ancestral alleles for both of these
mutations were extant at the founding of the AJ pop-
ulation, ∼1,200 YBP, as suggested by the coalescence
analyses, then the striking differences in mutation prev-
alence in the current AJ population highlight the im-
portance of demographic (or epigenetic) factors in the
shaping of allele frequencies, at least within this fre-
quency range. Although 84GG is a null allele that is
lethal in homozygosity (Tayebi et al. 1997; R. J. Desnick
and C. M. Eng, unpublished results), the negative-
selection coefficient is minimal, because of the low fre-
quency of other genetic-lethal GD alleles in the AJ pop-
ulation. Previous work by Risch et al. (1995) has
suggested that the present-day AJ population is not the
product of uniform population growth but, rather, is
derived primarily from expansion of a subpopulation.
The recent finding that the prevalence of Tay-Sachs car-
riers among carriers of GD is lower than would be ex-
pected on the basis of population-frequency data sug-
gests that these mutations have not yet reached genetic
equilibrium, a finding that is consistent with the pres-
ence of population subdivisions within the AJ popula-
tion (Peleg et al. 1998). Thus, a likely explanation for
the currently observed GD allele frequencies appears to
be nonuniform expansion of the AJ population after the
founding bottleneck. In support of this conclusion, com-
puter simulations modeling the introduction of disease
alleles into a rapidly growing population have produced
results consistent with skewing of disease-allele fre-
quencies, as is seen in the AJ population, in the absence
of selection and in the time frame under discussion (N.
Risch, personal communication). Taken as a whole, the
findings in this and other studies indicate the importance
of genetic drift in shaping the disease-allele frequencies
observed in the contemporary AJ population.
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Appendix
Estimation of Allele Frequencies in Disease Chromo-
somes, by EM Algorithm
Suppose that there are m marker alleles denoted 1–m.
Let pi represent the frequency of allele i on N370S chro-
mosomes, and let qi represent the frequency of allele i
on 84GG chromosomes. Let ai represent the number of
i alleles observed on N370S chromosomes (either from
homozygotes or from phased heterozygotes), and let bi
represent the corresponding number on 84GG chro-
mosomes, and let cij represent the number of ij genotypes
found on the N370S/84GG compound heterozygotes.
Let , , and (note that ). TheA = Sa B = Sb C = Sc c = ci i ij ij ji
following recursion formulas can then be used to obtain
the MLEs of pi and qi:
a 1 c O c ∗ p q /(p q 1 p q )i ii ij i j j i i j
j(i′p =i A 1 1/2C
and
b 1 c O c ∗ p q /(p q 1 p q )i ii ij i j j i i j
j(i′q = .i B 1 1/2C
Standard errors for the estimates of pi and qi can be
obtained by standard likelihood theory, by inverting
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the expected information matrix; for example, for fre-
quencies pi and qi, the respective variances, jp and
jq, are given by and
2 2 2j = q / (q q 2 q ) j =p 22 11 22 12 q
, where2q / (q q 2 q )11 11 22 12
A C(p 1 q 2 2p q )i i i i
q = 111 p (1 2 p ) p (1 2 p )i i i i
2C(1 2 2q )i1 ,
(p 1 q 2 2p q )i i i i
B C(p 1 q 2 2p q )i i i i
q = 122 q (1 2 q ) q (1 2 q )i i i i
2C(1 2 2p )i1 ,
(p 1 q 2 2p q )i i i i
and
C
q = .12 (p 1 q 2 2p q )i i i i
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